These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 6443775

  • 21. [Treatment of Pseudomonas aeruginosa infection in burn patients].
    Litovchenko PP, Nazarchuk LV, Degtiar NV, Abu-el-Khava MI, Gaĭduk VI.
    Klin Khir (1962); 1987; (3):24-7. PubMed ID: 3106703
    [No Abstract] [Full Text] [Related]

  • 22. Comparative in-vitro activity of cefsulodin and ceftazidime against ticarcillin-resistant Pseudomonas aeruginosa.
    Philippon A, Paul G, Nevot P.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():119-22. PubMed ID: 19810173
    [Abstract] [Full Text] [Related]

  • 23. [Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units].
    Lambert-Zechovsky N, Bingen E, Guihaire E, Nancy C, Mercier JC, Beaufils F.
    Presse Med; 1986 Dec 20; 15(46):2309-12. PubMed ID: 2949273
    [Abstract] [Full Text] [Related]

  • 24. Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics.
    Estahbanati HK, Kashani PP, Ghanaatpisheh F.
    Burns; 2002 Jun 20; 28(4):340-8. PubMed ID: 12052372
    [Abstract] [Full Text] [Related]

  • 25. Re: Pseudomonas aeruginosa isolates from burn patients in the Northwest of Pakistan.
    Arya SC, Agarwal N, Agarwal S.
    Burns; 2010 Aug 20; 36(5):739-40. PubMed ID: 20071094
    [No Abstract] [Full Text] [Related]

  • 26. Predictors of response to therapy for infections caused by Pseudomonas aeruginosa.
    Platt R.
    Rev Infect Dis; 1984 Aug 20; 6 Suppl 3():S759-68. PubMed ID: 6571340
    [Abstract] [Full Text] [Related]

  • 27. The evolution and spread of gentamicin-resistant Pseudomonads.
    Stone HH, Kolb LD.
    J Trauma; 1971 Jul 20; 11(7):586-9. PubMed ID: 4997242
    [No Abstract] [Full Text] [Related]

  • 28. Diagnostic multiplex polymerase chain reaction assay for the identification of Pseudomonas aeruginosa from the skin biopsy specimens in burn wound infections and detection of antibiotic susceptibility.
    Mashouf RY, Zamani A, Farahani HS.
    Saudi Med J; 2008 Aug 20; 29(8):1109-14. PubMed ID: 18690301
    [Abstract] [Full Text] [Related]

  • 29. [Experimental study of the local application of silver sulfadiazine, cefsulodin and povidone-iodine in burns].
    Kaiser W, von der Lieth H, Potel J, Heymann H.
    Infection; 1984 Aug 20; 12(1):31-5. PubMed ID: 6706410
    [Abstract] [Full Text] [Related]

  • 30. Gentamicin and cefsulodin efficacy in a rat abscess model.
    Rubinstein E, Dreznik Z, Mark Z.
    Surg Gynecol Obstet; 1982 Sep 20; 155(3):363-8. PubMed ID: 6810484
    [Abstract] [Full Text] [Related]

  • 31. Treatment of pulmonary Pseudomonas aeruginosa infection in cystic fibrosis with cefsulodin.
    Møller NE, Koch C, Vesterhauge S, Jensen K.
    Scand J Infect Dis; 1982 Sep 20; 14(3):207-11. PubMed ID: 6815787
    [Abstract] [Full Text] [Related]

  • 32. Characterization of Pseudomonas aeruginosa strains isolated from burned patients hospitalized in a major burn center in Tehran, Iran.
    Ranjbar R, Owlia P, Saderi H, Mansouri S, Jonaidi-Jafari N, Izadi M, Farshad S, Arjomandzadegan M.
    Acta Med Iran; 2011 Sep 20; 49(10):675-9. PubMed ID: 22071644
    [Abstract] [Full Text] [Related]

  • 33. Infection in burn patients in a referral center in Colombia.
    Ramirez-Blanco CE, Ramirez-Rivero CE, Diaz-Martinez LA, Sosa-Avila LM.
    Burns; 2017 May 20; 43(3):642-653. PubMed ID: 28185802
    [Abstract] [Full Text] [Related]

  • 34. Experimental efficacy of apalcillin and cefpiramide compared with that of six other antipseudomonal agents in Pseudomonas aeruginosa burn infections.
    Fu KP, Vince T, Hung PP, Gregory JF.
    Drugs Exp Clin Res; 1986 May 20; 12(4):303-6. PubMed ID: 3720518
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of Mannosidase and Trypsin Enzymes Effects on Biofilm Production of Pseudomonas aeruginosa Isolated from Burn Wound Infections.
    Banar M, Emaneini M, Satarzadeh M, Abdellahi N, Beigverdi R, Leeuwen WB, Jabalameli F.
    PLoS One; 2016 May 20; 11(10):e0164622. PubMed ID: 27736961
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Activity of cefsulodin and other agents against Pseudomonas aeruginosa.
    Neu HC, Scully BE.
    Rev Infect Dis; 1984 May 20; 6 Suppl 3():S667-77. PubMed ID: 6443768
    [Abstract] [Full Text] [Related]

  • 38. Intensive treatment of pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin.
    Conway SP, Miller MG, Ramsden C, Littlewood JM.
    Acta Paediatr Scand; 1985 Jan 20; 74(1):107-13. PubMed ID: 3885674
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Cefsulodin in the treatment of Pseudomonas meningitis].
    Brückner O, Collmann H, Trautmann M.
    Infection; 1983 Jan 20; 11(5):264-8. PubMed ID: 6642678
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.